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Introduction
Flavonoids are inherent part of human and animal diet 
however, these are not synthesized within the body of ani-
mals including human. In addition, these flavonoids are 
of plant origin but these are found in the highest concen-
tration in the human diet especially in the form of flavo-
nols; flavones and isoflavones (1,2). The main function 
of flavonoids is responsibility for plants colour, taste, ob-
struction of fat oxidation and protection of vitamins and 
enzymes. This group of natural compounds of medicinal 
plant products i.e. flavonoids has phenolic structures and 
these are based upon fifteen-carbon skeleton, incorporat-
ing two benzene rings linked via heterocyclic pyran ring 
(3,4). These flavonoids are ubiquitous in nature and cat-
egorized into flavonols, flavones, flavanones, isoflavones, 
catechins, anthocyanidins and chalcones. More than 4000 
flavonoids and their derivatives have already been identi-
fied out of which many of them are reported and isolated 
from fruits, vegetables and beverages (tea; coffee; beer; 
wine and fruit drinks) (5). Recently, scientists have fo-
cused on secondary metabolites especially flavonoids and 
have shown considerable interest because of their ben-
eficial effects on our immune system as well as antiviral 
(6); anti-allergic (7); anti-inflammatory (8); anti-tumor 
and antioxidant (9,10) activities. According to the litera-
ture, these flavonoids including antioxidants and enzymes 
can provide protection of our immune system against 
number of diseases (9,10). As per the epidemiological 
studies, intake of flavonoids is inversely proportional to 
mortality from coronary heart disease and prevalence 
of heart attacks (10,11).
Santalam album (commonly known as chandan or Indian 
sandalwood, family Santalaceae), is a small evergreen tree 
and may live to one hundred years of age. According to 
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Introduction: Medicinal plants have been used to treat various immunological diseases. Nitric 
oxide (NO) including proliferation and CD14 monocyte surface marker has played an important 
regulatory role in various types of inflammatory processes. This study was aimed to evaluate or 
scrutinize the effect of flavonoid extracted from the leaves of Santalum album, Butea frondosa and 
Emblica officinalis for determining their anti-inflammatory and immunosuppressive activity on 
human peripheral blood mononuclear cells (PBMC) using hepatitis B vaccine antigen (20 µg/mL; 
10 µl).
Methods: Flavonoids extracted from these medicinal plants were prepared (0.5–10 mg/mL; 50 µl) 
and their effects on human PBMC proliferation were examined using HBsAg. The NO production 
including CD14 monocyte surface marker was also estimated.
Results: All these flavonoids at higher doses demonstrated a significant decrease in proliferation, 
NO production and CD14 surface marker. This inhibitory effect was seen after 48 hours of 
treatment. 
Conclusion: These results may indicate the presence of anti-inflammatory and immunosuppressive 
activity in these medicinal plants.
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the literature, oil extracted from this medicinal plant i.e. 
Santalum album is commonly used for treatment of skin 
disorders, fever, urinary tract infection, heart ailments etc. 
In addition, Santalam album also possessed or showed 
anti-microbial and anti-inflammatory properties (12-14).
Medicinal plant Butea frondosa (also known as Palas; 
family Fabaceae), commonly found throughout India, Sri 
Lanka and Myanmar. It has shown the presence of phyto-
chemicals that are effective in various diseases. The leaves 
glycosides are used for sore throat and diabetes mellitus. 
The roots components including beta-sitosterol, amyrin, 
stigma sterol, etc have anti-microbial property, the seeds 
have proteolytic and lypolytic enzymes which have anthel-
mintic and antiparasitic properties (15-17).
Emblica officinalis (also known as Amla, family Phyllan-
thaceae) is growing throughout India and has shown its 
medicinal properties in a number of preclinical and clini-
cal studies to have. antipyretic, analgesic, wound healing, 
adjuvant, anti-anemia etc (18,19). As per these uses and 
properties of these three medicinal plants, this study was 
aimed to evaluate or scrutinize the effect of flavonoids ex-
tracted from the leaves of Santalum album, Butea fron-
dosa and Emblica officinalis for determining their anti-
inflammatory and immunosuppressive activity on human 
peripheral blood mononuclear cells (PBMC) using hepa-
titis B vaccine antigen (20 µg/mL; 10 µl).
Materials and methods
Collection of plant material
The leaves of medicinal plants (Santalum album, Butea 
frondosa and Emblica officinalis) were collected from the 
garden of Vidya Pratishthan’s School of Biotechnology 
(VSBT), Baramati, Maharashtra, India. These medicinal 
plant leaves were dried in a shady area after washing un-
der tap water and then with distilled water in order to re-
move the dust particles. The extraction of leaves was car-
ried out in liquid nitrogen by simple maceration process 
using mortar and pestle at room temperature in order to 
prepare the fine powder.
Extraction of flavonoids from medicinal plants
For flavonoid extraction from these medicinal plants (San-
talum album, Butea frondosa and Emblica officinalis), 50 g 
of fresh healthy plant leaves were macerated in liquid ni-
trogen using mortar and pestle to prepare grounded plant 
leaves powder and refluxed with 250 ml of 80% methanol 
for 3 hours at 90-100°C. Thereafter, the solution contain-
ing plant leaves powder was cooled down and preceded 
for filtration using Whatman filter paper (1,2). The filtrate 
was collected and then added in the ratio of 2:1 of distilled 
water and ethyl acetate. The samples were incubated for 
4-6 hours at room temperature, the upper layer (ethyl ac-
etate present) was collected and then the plant leaves ex-
tract was dried. Afterwards, the extracts were settled at the 
bottom and observed qualitatively the flavonoid content 
using lead acetate solution, yellow precipitation appears. 
This yellow color precipitation indicated the presence of 
flavonoid content (1,2).
PBMC proliferation assay
MTT (3-[4, 5-dimethylthiazol-2-y1]-2, 5- diphenyltet-
razolium bromide; yellow colour dye) is a quick, precise 
and sensitive in vitro method to evaluate the activity of 
flavonoids extracted from three medicinal plants on 
PBMC proliferation assay using hepatitis B surface anti-
gen (HBsAg). 
In order to study the proliferation of three medicinal 
plants using HBsAg, PBMC (105 cells/well) was cultured 
in 96 well cell culture plates along with variable concen-
trations of flavonoids (0.5–30 mg/ml; 50 µl). HBsAg (20 
µg/mL; 10 µl) was added to culture plates and kept in an 
atmosphere of 5% CO2 at 37°C for 24 hours. After that the 
media having flavonoid was removed after centrifuging 
and added 100µl fresh media in 96 well plates. Thereafter, 
MTT mixtures (2.5 mg/mL in PBS; 10 µl) were dispensed 
to all the wells of 96 well plates. The plates were placed 
in incubator (5% CO2 and 37°C) for 3-4 hours (12). The 
media was removed cautiously and the formazan crystals 
in all the columns were dissolved in Dimethyl sulfoxide 
(DMSO; 100 µl). The formazan end product was extrapo-
lated by measuring spectrophotometric absorbance at 
570 nm by enzyme linked immunosorbent assay (ELISA) 
plate reader.
Assay for nitric oxide production and CD14 monocyte 
surface marker
PBMC (105 cells/well) cells were incubated for 48 hours in 
presence of variable doses of flavonoids (0.5–30 mg/mL; 
50 µl) extracted from three medicinal plants along with 
or without HBsAg (20 µg/mL; 10 µl) in a final volume of 
0.2 mL and then supernatant was collected after centri-
fuging the plate. NO production was determined by mea-
suring the optical density (OD) of nitrite accumulated in 
the culture supernatant of these flavonoids along with or 
without HBsAg at 540 nm using the Griess reagent (1% 
sulfanilamide, 0.1% N-1-naphthylethylenediamine dihy-
drochloride in 2.5% phosphoric acid). The concentration 
of nitrite was determined through serial dilutions of so-
dium nitrite used as standard. All experiments were plated 
in triplicate wells and were performed at least three times 
(1,2,12). 
Similarly, CD14 monocyte surface marker in human 
PBMC was determined using flow cytometer. In this 
study, treated (flavonoids; 0.5–30 mg/mL; 50 µl)) and non 
treated (control) samples of human PBMC were stained 
with CD14 FITC monocyte surface marker. All these 
samples were incubated in dark for 30 minutes at room 
temperature and then lysed with red cell lysis. Then it 
was incubated (10 minutes in dark) and washed with PBS 
(2500 rpm, 4°C and 10 minutes). Finally, all these samples 
were analyzed through FACS Calibur (BD Biosciences) 
(1,2,12). 
Statistical analysis
All statistical data analysis was carried out by using one 
way analysis of variance (ANOVA) test (Bnferroni mul-
tiple comparison test). Data was presented as mean ± 
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standard error (SE). 
Results 
PBMC proliferation assay
The effect of flavonoids extracted from these medici-
nal plants on the growth and viability of these activated 
PBMC was assessed by MTT colorimetric assay. Experi-
mentation was done in 48 hours treatment of PBMC con-
taining variable doses of flavonoid along with HBsAg. The 
results showed that flavonoids at higher concentration de-
creased the proliferation containing HBsAg. HBsAg was 
used as standard and showed enhancement of prolifera-
tion as compared to control (Figure 1).
Nitric oxide production
HBsAg-stimulated PBMC was studied for NO release in 
the presence of flavonoids extracted from three medici-
nal plants. The flavonoids spontaneously declined in ni-
trite production from PBMC cell culture supernatant at 
higher doses as compared to control and standard HBsAg 
(Figure 2).
CD14 monocyte surface marker
The effects of flavonoids on CD14 monocyte marker are 
shown in Figure 3. The results showed that there was 
markedly decline in CD14 monocyte marker at higher 
doses as compared to control (Figure 3).
Discussion
In the present study, the focus was on secondary metabo-
lites especially flavonoids extracted from three medicinal 
plants (Santalum album, Butea frondosa and Emblica of-
ficinalis) native to India which were investigated for their 
anti-inflammatory and immunosuppressive effects on hu-
man PBMC using HBsAg. For these studies, firstly pro-
liferation assay of these flavonoids against human PBMC 
were studied and then their effects on the NO production 
were evaluated including CD14 monocyte surface marker. 
The flavonoids of these medicinal plants showed inhibi-
tory effects on HBsAg lymphocyte proliferation and also 
sudden decline was seen in the level of NO including 
CD14 monocyte surface marker at higher doses compared 
to the control after 48 hours of treatment. 
The inhibitory effects of these medicinal plants on PBMC 
proliferation as well as NO production including CD14 
marker can justify the therapeutic usefulness in rheuma-
toid arthritis which is an inflammatory disorder. The ca-
pacity of these medicinal plant products with respect to 
inhibition of B (humoral) and T (cell mediated) immune 
response provides useful applications in these immune 
mediated disorders. Both T and B lymphocytes activa-
tion including macrophages (PBMC) play critical roles 
in pathogenesis of these immunodeficiency’s or disor-
ders (10-12). PBMC (monocytes derived macrophages) is 
normally impenetrable in the inflammatory processes by 
generation of pro-inflammatory cytokines (IFN-gamma 
and TNF alpha) including proliferation and other inflam-
matory mediators such as NO and CD14 surface marker. 
These medicinal plants showed inhibition of proliferation, 
NO production and CD14 surface marker at higher doses 
 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
Control HBsAg, 20 µg 0.5 1 10 30
O
D 
at
 5
70
 n
m
 (M
ea
n 
±
S.
E.
)
Doses (mg/mL; 50 µl)
Santalum album
Butea frondosa
Emblica officinalis
***
**
**
*
*
*
*
*
*
**
*
Figure 1. Effect of variable doses of flavonoids extracted 
from the leaves of medicinal plants (Santalum album, 
Butea frondosa and Emblica officinalis) on human PBMC 
proliferation assay. Values are expressed as mean ± SE. The 
difference between the control, standard and treated samples 
of flavonoids is determined by one way ANOVA test (Bonferroni 
multiple comparison test).
Figure 2. Effect of variable doses of flavonoids extracted 
from the leaves of medicinal plants (Santalum album, Butea 
frondosa and Emblica officinalis) on NO production from 
human PBMC cell culture supernatant. Values are expressed 
as mean ± SE. The difference between the control, standard and 
treated samples of flavonoids is determined by one way ANOVA 
test (Bonferroni multiple comparison test).
Figure 3. Effect of variable doses of flavonoids extracted 
from the leaves of medicinal plants (Santalum album, Butea 
frondosa and Emblica officinalis) on human CD14 monocyte 
surface marker using flow cytometry. Values are expressed as 
mean ± SE. The difference between the control, standard and 
treated samples of flavonoids is determined by one way ANOVA 
test (Bonferroni multiple comparison test).
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as compared to control. NO is an important chemical me-
diator generated by endothelial cells, dendritic cells, mac-
rophages, neurons, etc and also involved in the regulation 
of various physiological processes. Excess concentration 
or production of NO is associated with several diseases. 
Normally, animal or human diseases can be character-
ized through lack or excess of NO production. In some 
circumstances, protection against a decrease in constitu-
tive NO production in the vasculature may intercept the 
development of vascular disease, while inhibition of un-
controlled NO production could also be a therapeutic tar-
get (20). These flavonoids showed drastic dwindle in NO 
production at higher doses as compared to control and 
showed its therapeutic effect.
Further confirmation of flavonoids extracted from San-
talum album, Butea frondosa and Emblica officinalis for 
their anti-inflammatory and immunosuppressive activity 
against HBsAg in human PBMC using CD14 monocyte 
surface marker were determined through flow cytometry. 
As per literature, CD14 (55 KDa glycoprotein) identifica-
tion marker on the surface of monocytes as well as mac-
rophages and several monoclonal antibodies binding to 
the same epitope on human monocytes were assigned to 
a provisional CD14 cluster, which was categorized or des-
ignated as leucocyte differentiation antigen (21). Finally, 
CD14 monocyte marker production markedly decline at 
higher doses of these medicinal plants and this marker es-
pecially CD14 may depend on cell types and their species 
origin as well as different cells having different require-
ments for signal transduction pathways. In particular, NO 
production is mainly released by human PBMC and de-
termination of CD14 surface marker is believed to play 
a considerable role in the pathophysiology of hormonal 
immune system.
Conclusion
The present study showed that these medicinal plants 
down-regulated the release of NO production by human 
PBMC. In addition, this effect is likely to be due to inhibi-
tion of CD14 monocyte marker. The NO down-regulation 
may reduce pathological harms arise due to an excess in 
NO production in inflammatory processes. Further study 
is needed to complete these data and to identify the re-
sponsible compounds. 
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